About this trial
This purpose of this study is to compare a new form of LASIK called Ray Tracing Guided LASIK to 3 other forms of corneal refractive surgery: 1. KLEx (KeratoLenticule Extraction) using the Zeiss Visumax 800 Laser, 2. WFO LASIK (Wavefront Optimized LASIK) using the Alcon EX500 Laser, and 3. Topography Guided LASIK (Contoura LASIK) also using the Alcon EX500 Laser.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age 22-50 at the time of consent
Diagnosis of myopia or myopia with astigmatism with Preoperative manifest spherical equivalent refraction of ≥ -2.00 and ≤ -9.00 D (-2.00 D through -9.00 D)
Preop Spherical component of ≥ -2.00 and ≤ -8.00 D (-2.00 D through -8.00 D)
Refractive Cylinder of ≤ -3.00 D (0.00 through -3.00 D)
Disqualifiers
Clinically significant dry eye on clinical examination, as determined by the investigator
Irregular astigmatism, keratoconus, keratoconus suspect, or abnormal corneal tomography
History of corneal dystrophies or guttata
History of herpetic keratitis or active disease
Trial design
Parallel
Treatments tested in this trial
Ray-Tracing Guided LASIK
DeviceA form of LASIK where Ray-Tracing technology is used to create the surgical profile for treating the cornea.
Keratorefractive Lenticule Extraction (KLEx)
DeviceA form of corneal refractive surgery utilizing a femtosecond laser to create a lens shaped lenticule of corneal tissue that is removed through a small corneal incision.
WaveFront Optimized LASIK
DeviceA form of LASIK where the corneal treatment profile is modified to decrease induced Spherical Aberration.
Topography Guided LASIK
DeviceA form of LASIK where a corneal topography of the cornea is used to create the surgical profile for treating the cornea.
Treatment groups
6
Treatment groupsSee each treatment group below.
Trial outcomes
Primary outcomes
Uncorrected Visual Acuity
Percentage of eyes acheiving uncorrected visual acuity of 20/40, 20/25, 20/20, 20/16, 20/12.5, and 20/10 at post-operative month 3, 6 and 12
Secondary outcomes
Predictability
Percentage of eyes that acheive MRSE within +/- 0.5 diopters and +/- 1.00 diopters of intended correction at post-operative visits 3, 6, and 12-months.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.